Quarter 3, 2025
Net sales decreased 4.5% to SEK 34,638m (36,274). Excl. currency translation effects, net sales increased SEK 322m.
Organic sales growth amounted to 0.9%, of which volume accounted for 0.2% and price/mix 0.7%
EBITA increased to SEK 5,152m (5,130)
EBITA excl. IAC decreased 1% to SEK 5,056m (5,097). Excl. currency translation effects, EBITA excl. IAC increased 5%, corresponding to SEK 278m.
EBITA margin excl. IAC increased 0.5 percentage points to 14.6% (14.1)
ROCE amounted to 17.9% (17.8) and ROCE excl. IAC to 17.6% (17.7)
Profit for the period, total operations, increased to SEK 3,358m (3,329).
Earnings per share, total operations, increased to SEK 4.86 (4.73).
On October 23, 2025, it was announced that an organizational change and a cost savings program are launched to create better conditions for profitable growth.
CEO'S COMMENTS
Our efforts to drive growth and reduce costs have yielded results and the third quarter developed favourably in continued challenging market conditions. In parallel, we are today launching measures aimed at creating better conditions for profitable growth - an organizational change and a cost savings program.
Positive organic sales growth
Organic growth was positive compared with the third quarter of the previous year, mainly driven by higher prices. Volumes and product mix also contributed positively. All business areas reported positive organic growth. Growth remained strong in Incontinence Products Retail, Feminine Care and Medical Solutions. However, Consumer Tissue noted negative growth, driven by lower volumes in Europe. In Professional Hygiene, Baby Care and Incontinence Health Care, we reported a positive ...
